Methods of epigenome editing for probing the function of genomic imprinting

Epigenomics

Volumn 8, Issue 10, 2016, Pages 1389-1398

  Rienecker, Kira D A ^a   Hill, Matthew J ^a   Isles, Anthony R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CRISPR Cas9; EpiEffectors; epigenome editing; functional consequences; imprinting

Indexed keywords

EPIGENETICS; GENE FUNCTION; GENE TARGETING; GENETIC ENGINEERING; GENOME IMPRINTING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENICS; ANIMAL; GENETIC EPIGENESIS; TRANSGENE;

ANIMALS; EPIGENESIS, GENETIC; GENETIC ENGINEERING; HUMANS; TRANSGENES;

EID: 84990866011     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi-2016-0073     Document Type: Review

References (45)

1. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature 414(6859), 122-128 (2001).
2. Sanz LA, Chamberlain S, Sabourin JC et al. A mono-allelic bivalent chromatin domain controls tissue-specific imprinting at Grb10. EMBO J. 27(19), 2523-2532 (2008).
3. Davies W, Isles AR, Humby T, Wilkinson LS. What are imprinted genes doing in the brain? Epigenetics 2(4), 201-206 (2007).
4. John RM, Lefebvre L. Developmental regulation of somatic imprints. Differentiation 81(5), 270-280 (2011).
5. Ideraabdullah FY, Vigneau S, Bartolomei MS. Genomic imprinting mechanisms in mammals. Mutat. Res. Fundam. Mol. Mech. Mutagen. 647(1), 77-85 (2008).
6. Wood AJ, Oakey RJ. Genomic imprinting in mammals: emerging themes and established theories. PLoS Genet. 2(11), e147 (2006).
7. Wilkins JF, Ubeda F, Van Cleve J. The evolving landscape of imprinted genes in humans and mice: conflict among alleles, genes, tissues, and kin. Bioessays 38(5), 482-489 (2016).
8. Keverne EB. Genomic imprinting in the brain. Curr. Opin. Neurobiol. 7(4), 463-468 (1997).
9. Charalambous M, da Rocha ST, Ferguson-Smith AC. Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. Curr. Opin. Endocrinol. Diabetes Obes. 14(1), 3-12 (2007).
10. Costa LM, Yuan J, Rouster J, Paul W, Dickinson H, Gutierrez-Marcos JF. Maternal control of nutrient allocation in plant seeds by genomic imprinting. Curr. Biol. 22(2), 160-165 (2012).
11. Tunster SJ, Jensen AB, John RM. Imprinted genes in mouse placental development and the regulation of fetal energy stores. Reproduction 145(5), R117-R137 (2013).
12. Champagne FA, Curley JP. Epigenetic mechanisms mediating the long-term effects of maternal care on development. Neurosci. Biobehav. Rev. 33(4), 593-600 (2009).
13. Lefebvre L, Viville S, Barton SC, Ishino F, Keverne EB, Surani MA. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat. Genet. 20(2), 163-169 (1998).
14. Isles AR, Holland AJ. Imprinted genes and mother-offspring interactions. Early Hum. Dev. 81(1), 73-77 (2005).
15. Dent CL, Isles AR. Brain-expressed imprinted genes and adult behaviour: the example of Nesp and Grb10. Mamm. Genome 25(1-2), 87-93 (2014).
16. Garfield AS, Cowley M, Smith FM et al. Distinct physiological and behavioural functions for parental alleles of imprinted Grb10. Nature 469(7331), 534-538 (2011).
17. Plagge A, Isles AR, Gordon E et al. Imprinted Nesp55 influences behavioral reactivity to novel environments. Mol. Cell. Biol. 25(8), 3019-3026 (2005).
18. McNamara GI, Isles AR. Dosage-sensitivity of imprinted genes expressed in the brain: 15q11-q13 and neuropsychiatric illness. Biochem. Soc. Trans. 41(3), 721-726 (2013).
19. Isles AR, Ingason A, Lowther C et al. Parental origin of interstitial duplications at 15q11.2-q13.3 in schizophrenia and neurodevelopmental disorders. PLoS Genet. 12(5), e1005993 (2016).
20. Tunster SJ, Creeth HDJ, John RM. The imprinted Phlda2 gene modulates a major endocrine compartment of the placenta to regulate placental demands for maternal resources. Dev. Biol. 409(1), 251-260 (2016).
21. John RM. Engineering mouse models to investigate the function of imprinting. Brief. Funct. Genomics 9(4), 294-303 (2010).
22. Charalambous M, Ferron SR, da Rocha ST et al. Imprinted gene dosage is critical for the transition to independent life. Cell Metab. 15(2), 209-221 (2012).
23. Tunster SJ, Van De Pette M, John RM. Isolating the role of elevated Phlda2 in asymmetric late fetal growth restriction in mice. Dis. Model. Mech. 7(10), 1185-1191 (2014).
24. Han L, Szabó PE, Mann JR. Postnatal survival of mice with maternal duplication of distal chromosome 7 induced by a Igf2/H19 imprinting control region lacking insulator function. PLoS Genet. 6(1), e1000803 (2010).
25. Ainscough JF, Koide T, Tada M, Barton S, Surani MA. Imprinting of Igf2 and H19 from a 130 kb YAC transgene. Development 124(18), 3621-3632 (1997).
26. Ripoche MA, Kress C, Poirier F, Dandolo L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev. 11(12), 1596-1604 (1997).
27. Jones MJ, Lefebvre L. An imprinted GFP insertion reveals long-range epigenetic regulation in embryonic lineages. Dev. Biol. 336(1), 42-52 (2009).
28. Schmidt JV, Matteson PG, Jones BK, Guan XJ, Tilghman SM. The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev. 14(16), 1997-2002 (2000).
29. Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S. Use of epigenetic drugs in disease: an overview. Genet. Epigenet. 6, 9-19 (2014).
30. Christman JK. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21(35), 5483-5495 (2002).
31. Laufer BI, Singh SM. Strategies for precision modulation of gene expression by epigenome editing: an overview. Epigenetics Chromatin. 8(1), 34-45 (2015).
32. Vojta A, Dobrinić P, Tadić V et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44(12), 5615-5628 (2016).
33. Perez-Pinera P, Kocak DD, Vockley CM et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10(10), 973-976 (2013).
34. Hilton IB, D'Ippolito AM, Vockley CM et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33(5), 510-517 (2015).
35. Polstein LR, Gersbach CA. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat. Chem. Biol. 11(3), 198-200 (2015).
36. Ling J, Baibakov B, Pi W, Emerson BM, Tuan D. The HS2 enhancer of the beta-globin locus control region initiates synthesis of non-coding, polyadenylated RNAs independent of a cis-linked globin promoter. J. Mol. Bio. 350(5), 883-896 (2005).
37. Lauc G, Huffman JE, Pučić M et al. Loci associated with N-Glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 9(1), e1003225 (2013).
38. Falaleeva M, Surface J, Shen M, de la Grange P, Stamm S. SNORD116 and SNORD115 change expression of multiple genes and modify each other's activity. Gene 572(2), 266-273 (2015).
39. Srivastava M, Hsieh S, Grinberg A, Williams-Simons L, Huang S, Pfiefer K. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19. Genes Dev. 14(10), 1186-1195 (2000).
40. Konermann S, Brigham MD, Trevino A et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500(7463), 472-476 (2013).
41. Bashtrykov P, Kungulovski G, Jeltsch A. Correction of aberrant imprinting by allele-specific epigenome editing. Clin. Pharmacol Ther. 99(5), 482-484 (2015).
42. Yoshimi K, Kaneko T, Voigt B, Mashimo T. Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform. Nat Commun. 5, 4240 (2014).
43. Swigut T, Wysocka J. H3K27 demethylases, at long last. Cell 131(1), 29-32 (2007).
44. Zetsche B, Gootenberg JS, Abudayyeh OO et al. CpF1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163(3), 759-771 (2015).
45. Fagerlund RD, Staals RH, Fineran PC. The Cpf1 CRISPRCas protein expands genome-editing tools. Genome Biol. 16(1), 251 (2015).